Acute Myeloid Leukemia

TREATMENT OPTIONS

Actor portrayal.

What are some of the common treatments for AML?

There are several options for treating AML. You and your healthcare provider will choose the most appropriate treatment for you.

AML can be treated with the help of cancer-fighting medicines, like VENCLEXTA (ven-KLEKS-tuh). Other common treatments for AML include:

Target symbol icon

Targeted therapy

These treatments "target" a specific protein, mutation, or receptor in the body and can include certain types of inhibitors. VENCLEXTA is an example of a targeted therapy.

Injection icon

Hypomethylating agents

Generally reserved for those who are older or who have other health conditions, these agents help restore the normal function of genes that suppress the formation of tumors.

IV bag icon

Chemotherapy

This treatment uses powerful chemicals to kill fast-growing cells in your body, including cancer cells. Standard chemotherapy can be given at a high or low dose, depending on the aggressiveness of the cancer and the patient’s ability to tolerate it based on other health factors.

Radiation Symbol

Radiation therapy

Only used for specific cases of AML, this treatment uses radiation to kill cancer cells and noncancerous cells or slow their growth by damaging their DNA. Cancer cells with DNA that is damaged beyond repair either stop dividing or die.

Stem cell icon

Stem cell transplant

This procedure transfers stem cells from a healthy donor to the patient or can be done using the patient’s own stem cells (autologous transplant). If successful, it can replace stem cells in the bone marrow. This procedure involves chemotherapy and possibly radiation to prepare the body.

Nurse icon

Supportive care

This involves the management of disease- and sometimes therapy-related symptoms and can range from services that help with cancer pain and fatigue to palliative care and distress management.

PATIENT BROCHURE

Learn about treatment with VENCLEXTA and how it works against AML

Actor portrayal.

Learn more about treating AML with VENCLEXTA